AU2002337909A1 - Apomorphine-containing dosage form for ameliorating male erectile dysfunction - Google Patents

Apomorphine-containing dosage form for ameliorating male erectile dysfunction

Info

Publication number
AU2002337909A1
AU2002337909A1 AU2002337909A AU2002337909A AU2002337909A1 AU 2002337909 A1 AU2002337909 A1 AU 2002337909A1 AU 2002337909 A AU2002337909 A AU 2002337909A AU 2002337909 A AU2002337909 A AU 2002337909A AU 2002337909 A1 AU2002337909 A1 AU 2002337909A1
Authority
AU
Australia
Prior art keywords
apomorphine
dosage form
erectile dysfunction
male erectile
containing dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002337909A
Inventor
Ragab El-Rashidy
Bruce Ronsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pentech Pharmaceuticals Inc
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Publication of AU2002337909A1 publication Critical patent/AU2002337909A1/en
Abandoned legal-status Critical Current

Links

AU2002337909A 2001-10-23 2002-10-21 Apomorphine-containing dosage form for ameliorating male erectile dysfunction Abandoned AU2002337909A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/044,588 2001-10-23

Publications (1)

Publication Number Publication Date
AU2002337909A1 true AU2002337909A1 (en) 2003-05-06

Family

ID=

Similar Documents

Publication Publication Date Title
HUP0102834A3 (en) Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
HUP0001089A3 (en) Dosage forms for ameliorating male erectile dysfunction
GB0117618D0 (en) Pharmaceutical dosage form
AU2002339378A1 (en) Compartmentalized dosage form
AU4583899A (en) Nasal administration of sildenafil for the treatment of erectile dysfunction
EP1448194A4 (en) Apomorphine-containing dosage form for ameliorating male erectile dysfunction
AU2001274649A1 (en) Topical preparation of alprostadil for the treatment of erectile dysfunction
PL360186A1 (en) Daily treatment for erectile dysfunction using a pde5 inhibitor
AU3048501A (en) An improved pharmaceutical composition for treating male erectile dysfunction
EP1424491A4 (en) Fuel feeder
AU5766300A (en) Male erectile prosthesis
GB0105893D0 (en) Pharmaceutically active compounds
GB0106631D0 (en) Pharmaceutically active compounds
AU2001284125A1 (en) Medicine for fighting against sexual dysfunction
AU2002337909A1 (en) Apomorphine-containing dosage form for ameliorating male erectile dysfunction
AU6733500A (en) Agents for ameliorating erectile dysfunction
EP1566181A4 (en) Novel medicament for ameliorating neurotransmission dysfunction diseases
EP1404806A4 (en) Male contraceptives
AU2001281396A1 (en) Novel compositions and methods for treatment of male erectile dysfunction
AU2002349381A1 (en) Male underwear
TW567751U (en) Underwear for male
GB0122399D0 (en) Dosage forms
AU2002310459A1 (en) Male contraceptives
GB0121677D0 (en) Dosage
ZA200006374B (en) Compound for the treatment of female sexual dysfunction.